Gender Medicine, ISSN 1550-8579, 2012, Volume 9, Issue 6, pp. 481 - 489
Abstract Background Outcome of patients with urothelial carcinoma of the bladder (UCB) varies between sexes. Although overall incidence is higher in men,...
Internal Medicine | radical cystectomy | gender | lymphovascular invasion | prognosis | time periods | urothelial carcinoma of the bladder | MEDICINE, GENERAL & INTERNAL | STAGE | EAU GUIDELINES | UPDATE | PROGRESSION | Multivariate Analysis | Age Factors | Blood Vessels - pathology | Humans | Middle Aged | Carcinoma - mortality | Male | Urinary Bladder Neoplasms - pathology | Female | Retrospective Studies | Carcinoma - secondary | Urinary Bladder Neoplasms - mortality | Neoplasm Invasiveness | Carcinoma - surgery | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Lymphatic Metastasis | Urinary Bladder Neoplasms - surgery | Cystectomy | Lymphatic Vessels - pathology | Sex Factors | Aged | Neoplasm Staging | Germany | Carcinoma | Universities and colleges | Analysis | Mortality | Patient outcomes | Cancer
Internal Medicine | radical cystectomy | gender | lymphovascular invasion | prognosis | time periods | urothelial carcinoma of the bladder | MEDICINE, GENERAL & INTERNAL | STAGE | EAU GUIDELINES | UPDATE | PROGRESSION | Multivariate Analysis | Age Factors | Blood Vessels - pathology | Humans | Middle Aged | Carcinoma - mortality | Male | Urinary Bladder Neoplasms - pathology | Female | Retrospective Studies | Carcinoma - secondary | Urinary Bladder Neoplasms - mortality | Neoplasm Invasiveness | Carcinoma - surgery | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Lymphatic Metastasis | Urinary Bladder Neoplasms - surgery | Cystectomy | Lymphatic Vessels - pathology | Sex Factors | Aged | Neoplasm Staging | Germany | Carcinoma | Universities and colleges | Analysis | Mortality | Patient outcomes | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. 181 - 191
Summary Background Vascular-targeted photodynamic therapy, a novel tissue-preserving treatment for low-risk prostate cancer, has shown favourable safety and...
Hematology, Oncology and Palliative Medicine | Prostatic Neoplasms - pathology | Prognosis | Follow-Up Studies | Photosensitizing Agents - therapeutic use | Risk Assessment | Humans | Middle Aged | Male | Survival Rate | Photochemotherapy | Neoplasm Grading | Bacteriochlorophylls - therapeutic use | Aged, 80 and over | Adult | Aged | Neoplasm Staging | Population Surveillance | Prostatic Neoplasms - drug therapy | Medical colleges | Health aspects | Prostate cancer | Risk factors | Cancer | Life Sciences | Human health and pathology | Pharmacology | Urology and Nephrology | Pharmaceutical sciences | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Hematology, Oncology and Palliative Medicine | Prostatic Neoplasms - pathology | Prognosis | Follow-Up Studies | Photosensitizing Agents - therapeutic use | Risk Assessment | Humans | Middle Aged | Male | Survival Rate | Photochemotherapy | Neoplasm Grading | Bacteriochlorophylls - therapeutic use | Aged, 80 and over | Adult | Aged | Neoplasm Staging | Population Surveillance | Prostatic Neoplasms - drug therapy | Medical colleges | Health aspects | Prostate cancer | Risk factors | Cancer | Life Sciences | Human health and pathology | Pharmacology | Urology and Nephrology | Pharmaceutical sciences | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2016, Volume 42, Issue 11, pp. 1736 - 1743
Abstract Objectives To examine perioperative and oncologic outcomes of open (ORC) and robot-assisted radical cystectomy (RARC) in bladder Cancer (BCa)...
Hematology, Oncology and Palliative Medicine | Surgery | Comparative effectiveness | Radical cystectomy | Bladder cancer | Robot-assisted | Open | SURGERY | CUMULATIVE ANALYSIS | UROTHELIAL CARCINOMA | RANDOMIZED CLINICAL-TRIAL | CLASSIFICATION | SOCIETY | PASADENA CONSENSUS PANEL | URINARY-DIVERSION | ONCOLOGY | RECOMMENDATIONS | PROSTATE-CANCER | COMPLICATIONS | Length of Stay | Urinary Bladder Neoplasms - mortality | Robotic Surgical Procedures | Humans | Middle Aged | Female | Male | Aged | Referral and Consultation | Urinary Bladder Neoplasms - surgery | Cystectomy - methods | Robotic surgery | Care and treatment | Cancer patients | Patient outcomes | Comparative analysis | Robots
Hematology, Oncology and Palliative Medicine | Surgery | Comparative effectiveness | Radical cystectomy | Bladder cancer | Robot-assisted | Open | SURGERY | CUMULATIVE ANALYSIS | UROTHELIAL CARCINOMA | RANDOMIZED CLINICAL-TRIAL | CLASSIFICATION | SOCIETY | PASADENA CONSENSUS PANEL | URINARY-DIVERSION | ONCOLOGY | RECOMMENDATIONS | PROSTATE-CANCER | COMPLICATIONS | Length of Stay | Urinary Bladder Neoplasms - mortality | Robotic Surgical Procedures | Humans | Middle Aged | Female | Male | Aged | Referral and Consultation | Urinary Bladder Neoplasms - surgery | Cystectomy - methods | Robotic surgery | Care and treatment | Cancer patients | Patient outcomes | Comparative analysis | Robots
Journal Article
World Journal of Urology, ISSN 0724-4983, 8/2010, Volume 28, Issue 4, pp. 543 - 547
The value of surgical resection of renal cell carcinoma (RCC) liver metastases still remains unclear.Of our study was to evaluate the efficacy of liver...
Nephrology | Metastasectomy | Liver metastases | Resection | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Survival | NONCOLORECTAL PRIMARY | PRIMARY TUMORS | HEPATIC METASTASES | MANAGEMENT | UROLOGY & NEPHROLOGY | CANCER | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Renal Cell - surgery | Liver Neoplasms - surgery | Male | Kidney Neoplasms - mortality | Liver Neoplasms - mortality | Young Adult | Carcinoma, Renal Cell - mortality | Carcinoma, Renal Cell - secondary | Adolescent | Adult | Female | Kidney Neoplasms - pathology | Aged | Retrospective Studies | Liver - surgery | Liver Neoplasms - secondary | Databases, Factual | Liver cancer | Cell research | Carcinoma, Renal cell | Metastasis | Comparative analysis | Liver
Nephrology | Metastasectomy | Liver metastases | Resection | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Survival | NONCOLORECTAL PRIMARY | PRIMARY TUMORS | HEPATIC METASTASES | MANAGEMENT | UROLOGY & NEPHROLOGY | CANCER | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Renal Cell - surgery | Liver Neoplasms - surgery | Male | Kidney Neoplasms - mortality | Liver Neoplasms - mortality | Young Adult | Carcinoma, Renal Cell - mortality | Carcinoma, Renal Cell - secondary | Adolescent | Adult | Female | Kidney Neoplasms - pathology | Aged | Retrospective Studies | Liver - surgery | Liver Neoplasms - secondary | Databases, Factual | Liver cancer | Cell research | Carcinoma, Renal cell | Metastasis | Comparative analysis | Liver
Journal Article
Human Pathology, ISSN 0046-8177, 2008, Volume 39, Issue 8, pp. 1258 - 1262
Summary Small cell carcinoma of the urinary bladder is a rare entity known as an aggressive tumor. As it is rarely associated with transitional cell carcinoma...
Pathology | Transitional cell carcinoma in situ | TP53 | Small cell carcinoma of the urinary bladder | PATHOLOGY | small cell carcinoma of the urinary bladder | transitional cell carcinoma in situ | URINARY-BLADDER | UROTHELIUM | Immunohistochemistry | Carcinoma in Situ - chemistry | Carcinoma, Small Cell - genetics | Carcinoma in Situ - pathology | Humans | Male | Urinary Bladder - pathology | Loss of Heterozygosity | Tumor Suppressor Protein p53 - genetics | Carcinoma, Small Cell - chemistry | Point Mutation | Cystectomy | Carcinoma in Situ - genetics | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - chemistry | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Mutation | Carcinoma, Small Cell - pathology | Urinary Bladder - chemistry | Carcinoma, Transitional Cell - genetics | Adenocarcinoma | Tumor proteins
Pathology | Transitional cell carcinoma in situ | TP53 | Small cell carcinoma of the urinary bladder | PATHOLOGY | small cell carcinoma of the urinary bladder | transitional cell carcinoma in situ | URINARY-BLADDER | UROTHELIUM | Immunohistochemistry | Carcinoma in Situ - chemistry | Carcinoma, Small Cell - genetics | Carcinoma in Situ - pathology | Humans | Male | Urinary Bladder - pathology | Loss of Heterozygosity | Tumor Suppressor Protein p53 - genetics | Carcinoma, Small Cell - chemistry | Point Mutation | Cystectomy | Carcinoma in Situ - genetics | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - chemistry | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Mutation | Carcinoma, Small Cell - pathology | Urinary Bladder - chemistry | Carcinoma, Transitional Cell - genetics | Adenocarcinoma | Tumor proteins
Journal Article
Journal of Endourology, ISSN 0892-7790, 11/2011, Volume 25, Issue S1, pp. P1 - A373
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 7/2011, Volume 18, Issue 7, pp. 2018 - 2025
A larger number of dissected lymph nodes (LN) during pelvic lymphadenectomy in patients with muscle-invasive transitional-cell carcinoma of the bladder treated...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | IMPACT | STANDARDIZATION | ONCOLOGY | URINARY-BLADDER | EXTENT | METASTASES | MINIMUM NUMBER | Carcinoma, Transitional Cell - mortality | Lymph Node Excision | Urinary Bladder Neoplasms - mortality | Pelvic Neoplasms - surgery | Follow-Up Studies | Neoplasm Invasiveness | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Pelvic Neoplasms - mortality | Male | Survival Rate | Treatment Outcome | Lymphatic Metastasis | Urinary Bladder Neoplasms - surgery | Cystectomy | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Transitional Cell - surgery | Pelvic Neoplasms - pathology | Care and treatment | Carcinoma | Patient outcomes | Analysis | Cancer
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | IMPACT | STANDARDIZATION | ONCOLOGY | URINARY-BLADDER | EXTENT | METASTASES | MINIMUM NUMBER | Carcinoma, Transitional Cell - mortality | Lymph Node Excision | Urinary Bladder Neoplasms - mortality | Pelvic Neoplasms - surgery | Follow-Up Studies | Neoplasm Invasiveness | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Pelvic Neoplasms - mortality | Male | Survival Rate | Treatment Outcome | Lymphatic Metastasis | Urinary Bladder Neoplasms - surgery | Cystectomy | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Transitional Cell - surgery | Pelvic Neoplasms - pathology | Care and treatment | Carcinoma | Patient outcomes | Analysis | Cancer
Journal Article
BJU International, ISSN 1464-4096, 09/2011, Volume 108, Issue 6, pp. 922 - 928
OBJECTIVE • To test whether β1‐adrenoceptor activation leads to phosphorylation of the β2‐adrenoceptor in human prostate tissue. PATIENTS AND METHODS • ...
G protein‐coupled receptor kinase (GRK) | lower urinary tract symptoms (LUTS) | smooth muscle | alphal‐blocker | alphal‐adrenoceptor | prostate hyperplasia | alphal-blocker | alphal-adrenoceptor | G protein-coupled receptor kinase (GRK) | Immunohistochemistry | Prostatic Neoplasms - metabolism | Humans | Maleimides - pharmacology | Male | G-Protein-Coupled Receptor Kinase 2 - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Prostate - metabolism | Receptors, Adrenergic, beta-2 - metabolism | Adrenergic alpha-1 Receptor Agonists - pharmacology | Adrenergic beta-Agonists | Isoquinolines - pharmacology | Phenylephrine - pharmacology | G-Protein-Coupled Receptor Kinase 1 - metabolism | Indoles - pharmacology | Protein Kinase Inhibitors - pharmacology | Receptors, Adrenergic, beta-1 - drug effects | Phosphorylation - drug effects | GTP-Binding Proteins - metabolism | prostate hyperplasia; lower urinary tract symptoms (LUTS); smooth muscle; alphal-adrenoceptor; alphal-blocker; G protein-coupled receptor kinase (GRK) | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
G protein‐coupled receptor kinase (GRK) | lower urinary tract symptoms (LUTS) | smooth muscle | alphal‐blocker | alphal‐adrenoceptor | prostate hyperplasia | alphal-blocker | alphal-adrenoceptor | G protein-coupled receptor kinase (GRK) | Immunohistochemistry | Prostatic Neoplasms - metabolism | Humans | Maleimides - pharmacology | Male | G-Protein-Coupled Receptor Kinase 2 - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Prostate - metabolism | Receptors, Adrenergic, beta-2 - metabolism | Adrenergic alpha-1 Receptor Agonists - pharmacology | Adrenergic beta-Agonists | Isoquinolines - pharmacology | Phenylephrine - pharmacology | G-Protein-Coupled Receptor Kinase 1 - metabolism | Indoles - pharmacology | Protein Kinase Inhibitors - pharmacology | Receptors, Adrenergic, beta-1 - drug effects | Phosphorylation - drug effects | GTP-Binding Proteins - metabolism | prostate hyperplasia; lower urinary tract symptoms (LUTS); smooth muscle; alphal-adrenoceptor; alphal-blocker; G protein-coupled receptor kinase (GRK) | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2018, Volume 175, Issue 11, pp. 2077 - 2096
Background and Purpose In men with benign prostatic hyperplasia, increased smooth muscle tone in the prostate may lead to bladder outlet obstruction and...
CELLS | THERAPY | HYPERPLASTIC HUMAN PROSTATE | CONCISE GUIDE | COFILIN ACTIVITY | PHOSPHORYLATION | URINARY-TRACT SYMPTOMS | RHO-KINASE | PROTEIN-COUPLED RECEPTORS | PHARMACOLOGY & PHARMACY | ACTIN DYNAMICS | Actin Depolymerizing Factors - analysis | Cell Survival - drug effects | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Electric Stimulation | Humans | Cells, Cultured | Male | Lim Kinases - metabolism | Actin Depolymerizing Factors - metabolism | Muscle, Smooth - drug effects | Protein Kinase Inhibitors - chemistry | Lim Kinases - analysis | Lim Kinases - antagonists & inhibitors | Muscle Contraction - drug effects | Protein Kinase Inhibitors - pharmacology | Muscle, Smooth - pathology | Prostatic Neoplasms - drug therapy | Phosphorylation | Target recognition | Hyperplasia | Medical services | Bladder | Smooth muscle | Urinary tract | Kinases | Tissues | Filaments | Actin | Phenylephrine | Cofilin | Inhibition | Medical treatment | Muscles | Muscle contraction | Molecular chains | Substrates | Inhibitors | Stromal cells | LIM kinase | Adrenergic receptors | Immunofluorescence | Prostate | Viability | Research Papers | Research Paper
CELLS | THERAPY | HYPERPLASTIC HUMAN PROSTATE | CONCISE GUIDE | COFILIN ACTIVITY | PHOSPHORYLATION | URINARY-TRACT SYMPTOMS | RHO-KINASE | PROTEIN-COUPLED RECEPTORS | PHARMACOLOGY & PHARMACY | ACTIN DYNAMICS | Actin Depolymerizing Factors - analysis | Cell Survival - drug effects | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Electric Stimulation | Humans | Cells, Cultured | Male | Lim Kinases - metabolism | Actin Depolymerizing Factors - metabolism | Muscle, Smooth - drug effects | Protein Kinase Inhibitors - chemistry | Lim Kinases - analysis | Lim Kinases - antagonists & inhibitors | Muscle Contraction - drug effects | Protein Kinase Inhibitors - pharmacology | Muscle, Smooth - pathology | Prostatic Neoplasms - drug therapy | Phosphorylation | Target recognition | Hyperplasia | Medical services | Bladder | Smooth muscle | Urinary tract | Kinases | Tissues | Filaments | Actin | Phenylephrine | Cofilin | Inhibition | Medical treatment | Muscles | Muscle contraction | Molecular chains | Substrates | Inhibitors | Stromal cells | LIM kinase | Adrenergic receptors | Immunofluorescence | Prostate | Viability | Research Papers | Research Paper
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 4470 - 19
Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and...
TUMOR-INFILTRATING LYMPHOCYTES | SURVIVAL | CELLS | GENETICS | IMAGES | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | PATHOLOGY | Learning algorithms | Image processing | CD8 antigen | Glands | Data processing | Prostate | Prostate cancer | Vascularization
TUMOR-INFILTRATING LYMPHOCYTES | SURVIVAL | CELLS | GENETICS | IMAGES | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | PATHOLOGY | Learning algorithms | Image processing | CD8 antigen | Glands | Data processing | Prostate | Prostate cancer | Vascularization
Journal Article
Der Urologe, ISSN 0340-2592, 11/2017, Volume 56, Issue 11, pp. 1381 - 1382
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 10/2011, Volume 8, Issue 10, pp. 2678 - 2680
Journal Article
Neurourology and Urodynamics, ISSN 0733-2467, 09/2018, Volume 37, Issue 7, pp. 2128 - 2134
Aim To examine putative interaction between adrenergic and muscarinic contractile activation in the human urinary outflow tract. Methods Tissue from the...
alpha‐adrenoceptor | synergy | Rho kinase | trigone | prostate | muscarinic receptor | protein kinase c | alpha-adrenoceptor | ACTIVATION | MUSCLE | RESPONSES | BLADDER TRIGONE | UROLOGY & NEPHROLOGY | PHYSIOLOGICAL CONSIDERATIONS | Protein kinases | Analysis | Phenylephrine | Potentiation | Protein kinase C | Acetylcholine receptors (muscarinic) | Contractility | Myocytes | Kinases | Rho-associated kinase | Urethra | Carbachol | Adrenergic receptors | Receptor mechanisms | Immunofluorescence | Localization
alpha‐adrenoceptor | synergy | Rho kinase | trigone | prostate | muscarinic receptor | protein kinase c | alpha-adrenoceptor | ACTIVATION | MUSCLE | RESPONSES | BLADDER TRIGONE | UROLOGY & NEPHROLOGY | PHYSIOLOGICAL CONSIDERATIONS | Protein kinases | Analysis | Phenylephrine | Potentiation | Protein kinase C | Acetylcholine receptors (muscarinic) | Contractility | Myocytes | Kinases | Rho-associated kinase | Urethra | Carbachol | Adrenergic receptors | Receptor mechanisms | Immunofluorescence | Localization
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0137824
Purpose This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term...
COLORECTAL SURGERY | MORTALITY | SURGICAL-PATIENTS | SCREENING SCALE | DELIRIUM | POSTOPERATIVE COMPLICATIONS | MULTIDISCIPLINARY SCIENCES | OUTCOMES | PREOPERATIVE EDUCATION | ELDERLY-PATIENTS | LIFE | Length of Stay | Prospective Studies | Tertiary Care Centers | Humans | Gastrointestinal Neoplasms - surgery | Pain, Postoperative | Male | Treatment Outcome | Thoracic Neoplasms - surgery | Patient Participation - methods | Perioperative Care - methods | Quality of Life | Female | Surveys and Questionnaires | Aged | Urogenital Neoplasms - surgery | Postoperative Complications | Germany | Quality of Health Care | Patient Education as Topic | Medical care | Clinical trials | Cancer patients | Care and treatment | Patients | Quality management | Intervention | Elderly people | Intensive care | Colorectal cancer | Ovarian cancer | Empowerment | Randomization | Pain | Robustness (mathematics) | Intestine | Surgery | Anesthesia | Colorectal surgery | Public health | Diaries | Life expectancy | Complications | Mortality | Gynecology | Thorax | Morbidity | Cancer surgery | Quality of life | Medicine | Studies | Medical centres | Hospitals | Surgeons | Anesthesiology | German language | Elderly | Geriatrics | Cancer
COLORECTAL SURGERY | MORTALITY | SURGICAL-PATIENTS | SCREENING SCALE | DELIRIUM | POSTOPERATIVE COMPLICATIONS | MULTIDISCIPLINARY SCIENCES | OUTCOMES | PREOPERATIVE EDUCATION | ELDERLY-PATIENTS | LIFE | Length of Stay | Prospective Studies | Tertiary Care Centers | Humans | Gastrointestinal Neoplasms - surgery | Pain, Postoperative | Male | Treatment Outcome | Thoracic Neoplasms - surgery | Patient Participation - methods | Perioperative Care - methods | Quality of Life | Female | Surveys and Questionnaires | Aged | Urogenital Neoplasms - surgery | Postoperative Complications | Germany | Quality of Health Care | Patient Education as Topic | Medical care | Clinical trials | Cancer patients | Care and treatment | Patients | Quality management | Intervention | Elderly people | Intensive care | Colorectal cancer | Ovarian cancer | Empowerment | Randomization | Pain | Robustness (mathematics) | Intestine | Surgery | Anesthesia | Colorectal surgery | Public health | Diaries | Life expectancy | Complications | Mortality | Gynecology | Thorax | Morbidity | Cancer surgery | Quality of life | Medicine | Studies | Medical centres | Hospitals | Surgeons | Anesthesiology | German language | Elderly | Geriatrics | Cancer
Journal Article